↓ Skip to main content

ADAM8 in squamous cell carcinoma of the head and neck: a retrospective study

Overview of attention for article published in BMC Cancer, February 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
1 news outlet
patent
1 patent

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
ADAM8 in squamous cell carcinoma of the head and neck: a retrospective study
Published in
BMC Cancer, February 2012
DOI 10.1186/1471-2407-12-76
Pubmed ID
Authors

Valerie Zielinski, Markus Brunner, Gregor Heiduschka, Sven Schneider, Rudolf Seemann, Boban Erovic, Dietmar Thurnher

Abstract

A disintegrin and metalloproteinase (ADAMs) have been associated with multiple malignancies. ADAMs are involved in cell fusion, cell migration, membrane protein shedding and proteolysis. ADAM8 has been found to be overexpressed in squamous cell carcinomas of the lung. A new study showed that ADAM8 is significantly overexpressed in metastasis of squamous cell carcinomas of the head and neck (HNSCC).

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Poland 1 5%
Germany 1 5%
Unknown 18 90%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 3 15%
Researcher 3 15%
Other 2 10%
Student > Bachelor 2 10%
Student > Ph. D. Student 2 10%
Other 4 20%
Unknown 4 20%
Readers by discipline Count As %
Medicine and Dentistry 8 40%
Agricultural and Biological Sciences 4 20%
Veterinary Science and Veterinary Medicine 1 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Biochemistry, Genetics and Molecular Biology 1 5%
Other 2 10%
Unknown 3 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 August 2023.
All research outputs
#2,951,326
of 24,253,070 outputs
Outputs from BMC Cancer
#602
of 8,614 outputs
Outputs of similar age
#17,593
of 158,742 outputs
Outputs of similar age from BMC Cancer
#7
of 79 outputs
Altmetric has tracked 24,253,070 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,614 research outputs from this source. They receive a mean Attention Score of 4.5. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 158,742 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 79 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.